|
|
NeuroVentures
developing portfolio of leading CNS companies includes:
|
|
|
385
Oyster Point Blvd, Suite 9A
South
San Francisco, CA
94080
Phone: 650-875-7700
www.acumenpharm.com
|
Acumen Pharmaceuticals, Inc.
is an early-stage, drug discovery company committed to developing novel,
disease-modifying therapeutics for Alzheimer's disease and mild cognitive
impairment.
|
|
|
|
|
10835 Road To The Cure, Suite 150
San
Diego, CA
92121
Phone: 858 812 7700
Fax: 858 812 7630
www.braincellsinc.com
|
BrainCells, Inc. is an early stage, neurogenesis-based
drug discovery and development company targeting novel therapies for
depression, recovery from brain injury and other CNS diseases.
|
|
|
|
2585
Leghorn Street
Mountain
View, CA
94043
Phone: 650-938-2100
Fax: 650-938-2700
www.concentric-medical.com
|
Concentric Medical, Inc. is
pioneering new interventional approaches to treating ischemic and
hemorrhagic stroke. The company’s MERCITM Retrieval System, a mechanical
clot retrieval system, was approved by the FDA in August 2004 for use as
a primary tool for intervening in acute ischemic stroke. The MERCI System is available at over
50 leading stroke centers and major hospitals in the US.
|
|
|
|
7100
Foxborough Blvd, Suite 240
Foxborough,
MA 02035
Phone: 508-549-9981
Fax: 508-549-9985
www.cyberkineticsinc.com
|
Cyberkinetics Neurotechnology Systems, Inc. (CYKN.OB) is a publicly traded clinical-stage company, pioneer in neurotechnology, a new and rapidly developing field at
the crossroads of neurobiology, engineering and computer
science.
|
|
|
|
480
Arsenal Street, Bldg.1
Watertown,
MA 02472
Phone: 617-225-4250
Fax: 617-225-4267
www.envivopharma.com
|
EnVivo Pharmaceuticals Inc. is a biopharmaceutical company dedicated to discovering and
developing therapeutics for disorders of the brain, such as Alzheimer's,
Parkinson's, and Huntington’s Disease.
(Position sold in October
2002)
|
|
|
|
5251California Ave., Suite 210
Irvine, CA 92612
Phone:
949-725-3700
Fax:
949-725-3703
www.kadmuspharmaceuticals.com
|
Kadmus Pharmaceuticals Inc.
is a biotechnology company dedicated to the
development and commercialization of products targeting critical pathways
contributing to pain, obesity, and anxiety.
|
|
|
|
2240
Speakman Drive
Sheridan Science and Technology Park
Mississauga, ON
L5K 1A9
Phone:
905-823-3110
www.nrxn.com
|
Neuraxon Inc.
is developing new drugs for the treatment of migraine, pain and other CNS
disorders.
|
|
|
|
2555
Marconi Drive, Suite 220
Alpharetta, GA
30005
Phone:
770-753-4848
Fax: 770-753-4937
www.proximatherapeutics.com
|
Proxima
Therapeutics, Inc. is a
privately held medical device company that develops and markets
site-specific cancer treatment systems for breast and brain tumors.
(In March 2005, Proxima was acquired by Cytyc Corporation)
|
|
|
|
325 Barracks Hill
Charlottesville,
VA 22901
Phone: 434- 973-0177
www.rivannapharma.com
|
Rivanna Pharmaceuticals Inc. is a privately held,
discovery stage biopharmaceutical company engaged in the development of
novel small molecule therapeutics for the treatment of neurological
diseases and cancer.
|
|
|
|
60 Stone Pine Road, Suite 200
Half Moon Bay, California
94019
Phone:
650-560-0210
Fax: 650-560-0211
www.saegispharma.com
|
Saegis Pharmaceuticals, Inc. is dedicated to developing new medicines
that protect and improve memory and cognition.
|
|
|
|
Charlottesville, VA
|
Setagon, Inc. is developing next generation drug delivery technologies for the
intravascular treatment of cardiovascular, peripheral vascular and neurovascular
disease.
|
|
|
|
200 Boston Ave., Suite 3600
Medford,
MA 02155
Phone: 781-391-1900
Fax: 781-306-0880
www.scionpharma.com
|
Scion Pharmaceuticals, Inc. is focused on identifying and optimizing small-molecule drugs for
the treatment of central nervous system disorders and cardiovascular
diseases.
|
|
|
|
Two
Enterprise Drive, Suite 302
Shelton,
CT 06484
Phone: 203-944-9494
Fax: 203-944-9493
|
SpineWave, Inc. is a start-up company developing minimally
invasive therapies to address low back pain and spinal degeneration.
|
|
